Tramadol Hydrochloride
Product Images NDC 53002-4320

4 FDA label images from Rpk Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Tramadol Hydrochloride (NDC 53002-4320). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

10 (Tramadol HCl Tablets 1)

10 (Tramadol HCl Tablets 1)
Chemical structure of tramadol hydrochloride, showing the molecular framework including the cyclohexane ring, hydroxyl group, methoxy-substituted aromatic ring, and dimethylaminomethyl side chain, along with its hydrochloride component.*
FDA Label Image

10 (Tramadol HCl Tablets 2)

10 (Tramadol HCl Tablets 2)
A pharmacokinetic profile chart showing blood concentration (ng/mL) over time (hours) for Tramadol and its metabolite M1 after single and multiple doses. The chart compares concentration curves for multiple doses and single doses of Tramadol and M1 from 0 to 48 hours.*
FDA Label Image

10 (Tramadol HCl Tablets 3)

10 (Tramadol HCl Tablets 3)
A line graph titled 'Protocol CAPSS-047 Time to Discontinuation Due to Nausea/Vomiting' showing percent of participants discontinuing treatment on the vertical axis versus days in a double-blind study on the horizontal axis. The graph compares two dosing regimens to 200 mg/day over 10 days (solid red line) and 16 days (dashed blue line), indicating a higher discontinuation percentage with the 10-day regimen.*
FDA Label Image

Label Image (Lbl530024320)

Label Image (Lbl530024320)
Packaging label for Tramadol Hydrochloride 50 mg tablets by RPK Pharmaceuticals, Inc. The label indicates a supply of 20 tablets with directions to take one tablet every 4 to 6 hours as needed or as directed. The label includes patient name and clinic name fields, lot number, expiration date, and various billing NDC codes. The product is designated as Schedule IV (C-IV) and prescription only (Rx only).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.